Cited by 1,200Fungal Infections and StudiesAntifungal resistance and susceptibilityHistiocytic Disorders and Treatments

Histoplasmosis: a Clinical and Laboratory Update

Open access
Kauffman, Carol A.·2007·Clinical Microbiology Reviews

Abstract

SUMMARY: Infection with Histoplasma capsulatum occurs commonly in areas in the Midwestern United States and Central America, but symptomatic disease requiring medical care is manifest in very few patients. The extent of disease depends on the number of conidia inhaled and the function of the host's cellular immune system. Pulmonary infection is the primary manifestation of histoplasmosis, varying from mild pneumonitis to severe acute respiratory distress syndrome. In those with emphysema, a chronic progressive form of histoplasmosis can ensue. Dissemination of H. capsulatum within macrophages is common and becomes symptomatic primarily in patients with defects in cellular immunity. The spectrum of disseminated infection includes acute, severe, life-threatening sepsis and chronic, slowly progressive infection. Diagnostic accuracy has improved greatly with the use of an assay for Histoplasma antigen in the urine; serology remains useful for certain forms of histoplasmosis, and culture is the ultimate confirming diagnostic test. Classically, histoplasmosis has been treated with long courses of amphotericin B. Today, amphotericin B is rarely used except for severe infection and then only for a few weeks, followed by azole therapy. Itraconazole is the azole of choice following initial amphotericin B treatment and for primary treatment of mild to moderate histoplasmosis.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1128/cmr.00027-06

Cites

176 of 176 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Histoplasma capsulatum is an opportunistic pathogen that infects the respiratory system of mammals, causing histoplasmosis.

    “Histoplasma capsulatum is another opportunistic pathogen that infects the respiratory system of mammals, causing histoplasmosis (85).”

    From <i>Candida albicans</i> Biofilms and Human Disease (2015) · cites this paper as [85]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 5

  1. [22]Davis, A., D. Pierson, and J. E. Loyd. 2001. Mediastinal fibrosis. Semin. Respir. Infect. 16:119-130. [DOI] [PubMed] [Google Scholar]
  2. [92]Odio, C. M., M. Navarrete, J. M. Carrillo, L. Mora, and A. Carranza. 1999. Disseminated histoplasmosis. Pediatr. Infect. Dis. J. 18:1065-1068. [DOI] [PubMed] [Google Scholar]
  3. [123]Sutliff, W. D., C. E. Andrews, E. Jones, R. T. Terry, et al. 1964. Histoplasmosis cooperative study. Am. Rev. Respir. Dis. 89:641-650.14145215 [Google Scholar]
  4. [154]Wheat, L. J., and C. A. Kauffman. 2003. Histoplasmosis. Infect. Dis. Clin. N. Am. 17:1-19. [DOI] [PubMed] [Google Scholar]
  5. [163]Woods, J. P., E. L. Heinecke, J. W. Luecke, E. Malsonado, J. Z. Ng, D. M. Retallack, and M. M. Timmerman. 2001. Pathogenesis of Histoplasma capsulatum. Semin. Respir. Infect. 16:91-101. [DOI] [PubMed] [Google Scholar]

Cited by

Sorted by citations

Authors
Kauffman, C. A.
Affiliations
University of Michigan (US)
Corresponding author
Kauffman, Carol A.
Venue
Clinical Microbiology Reviews
Published
2007-01
Volume
20
Issue
1
Pages
115-132
ISSN
  • 0893-8512 (ISSN-L)
  • 1098-6618
OpenAlex
W2150499428
Cited by
1,200
References
176
Citations by year
2026: 39 · 2025: 58 · 2024: 53 · 2023: 91 · 2022: 71 · 2021: 63 · 2020: 93 · 2019: 84 · 2018: 67 · 2017: 86 · 2016: 61 · 2015: 62 · 2014: 59 · 2013: 62 · 2012: 62
FWCI
4.99
Type
journal article
Language
en
Open access
Locations
  • Clinical Microbiology Reviews (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Epidemiology › Fungal Infections and Studies
  • Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
  • Health Sciences › Medicine › Physiology › Histiocytic Disorders and Treatments
Keywords
histoplasmosis, Histoplasma capsulatum, pulmonary histoplasmosis, disseminated histoplasmosis, acute respiratory distress syndrome, emphysema, cell-mediated immunity, serology, culture diagnosis, amphotericin B, itraconazole, azole therapy, sepsis
MeSH terms
Amphotericin B, Antifungal Agents, Central Nervous System Diseases, Endocarditis, Histoplasmosis, Humans, Lung Diseases, Fungal, Mediastinitis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review